Gallium nitrate modulates bacterial biofilm development and virulence, with its antimicrobial effect largely dependent on pykF upregulation. Concurrent therapeutic targeting of both pykF and gallium may provide a more effective strategy against persistent biofilm-associated infections. This work also establishes a mechanistic basis for clinical approaches aimed at reducing biofilm formation and limiting device-related infections.
Zhang et al. (Fri,) studied this question.